RACHEL PAYNE: Open Payments
NPI 1619650215 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $514 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $94 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: CAPLYTA, Auvelity, UZEDY, REXULTI, SPRAVATO, COBENFY.
Industry payments across IN — which companies pay providers there.
